Researchers at the Stanford University School of Medicine discovered that when a molecule responsible for dialing down the immune system malfunctions in the brain cells of mice, the rodents develop symptoms of the degenerative brain disease.
Children’s Hospital Oakland Research Institute in California publishes new research that identifies a specific human enzyme that could kill cancer cells.
Scientists at UC Irvine have determined that levels of atmospheric methane — an influential greenhouse gas — have stayed nearly flat for the past seven years, which follows a rise that spanned at least two decades.
Educational policy discourse supports the idea that increases in science and mathematics achievement correlate to nation-wide economic gains. However, a thought-provoking new study from the American Journal of Education challenges the perceived causal links between educational achievement and economic growth. Francisco O. Ramirez (Stanford University) and his co-authors find that without the so-called “Asian Tigers,” the correlation diminishes and all but disappears.
The following are based on abstracts presented at the American Association for Cancer Research?s Fifth Annual International Conference on Frontiers in Cancer Prevention Research held November 12 ? 15 in Boston.
The news that the world’s first targeted therapy, trastuzumab (Herceptin), is now available for many women with early-stage HER2-positive breast cancer “highlights a truly significant advance in the management of breast cancer,” says Edith Perez, M.D., director of Mayo Clinic’s Breast Clinic in Jacksonville, Fla.
GlaxoSmithKline (GSK) and NeuroSearch have agreed to expand the scope of the current 5-year strategic alliance within CNS and ion channel drug discovery and development:
Novartis has received a positive opinion supporting European Union regulatory approval for Lucentis? (ranibizumab) as a new treatment option for patients with the “wet” form of age-related macular degeneration, the leading cause of severe vision loss in people over age 50 in the western world.
Chop off a salamander’s leg and a brand new one will sprout in no time. But most animals have lost the ability to replace missing limbs. Now, a research team at the Salk Institute for Biological Studies has been able to regenerate a wing in a chick embryo — a species not known to be able to regrow limbs — suggesting that the potential for such regeneration exists innately in all vertebrates, including humans.
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) reported today that a study published in the advanced online edition of the journal Nature supported and elaborated TB4’s significant effects in the damaged hearts of mice and highlighted its therapeutic potential for the treatment of heart attacks and heart failure in humans.